Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Virus-specific T-cell guided immunosuppression and antiviral management in pediatric kidney transplant recipients
2009-012436-32Phase 3Completed
- Sponsor
- Medizinische Hochschule Hannover
- Start
- Jul 2009
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cyclosporine in viral infection and kidney transplant immunosuppression (2 arms), sponsored by Medizinische Hochschule Hannover. Primary endpoint: Glomerular filtration rate. Started Jul 2009; status: completed.
02
Drugs
cyclosporine
03
Conditions
viral infectionkidney transplant immunosuppression
Beyond the preview
Go deeper on 2009-012436-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012436-32.